Abstract 3423: NX-2127: A first-in-class clinical stage degrader of BTK and IKZF1/3 for the treatment of patients with B cell malignancies
暂无分享,去创建一个
Brandon J. Bravo | Stephanie L. Yung | J. Mcintosh | R. Rountree | J. Mihalic | Jordan Ye | Timothy G Ingallinera | Ratul Mukerji | Jun Ma | Nivetha Brathaban | Jeffrey H. Wu | M. Tan | L. Perez | M. Noviski | A. Tenn-McClellan | Hao Lu | Daisuke Kato | Ge Peng